AbCellera Biologics Inc.
ABCL
$3.65
$0.082.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.67% | -22.93% | -17.49% | -13.29% | -17.75% |
| Total Receivables | 66.50% | 152.01% | 126.53% | 84.10% | 43.10% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 12.10% | 31.28% | 25.96% | -62.18% | -60.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Current Assets | -3.08% | -6.43% | -3.81% | -6.02% | -13.83% |
|
|
|||||
| Total Current Assets | -3.08% | -6.43% | -3.81% | -6.02% | -13.83% |
| Net Property, Plant & Equipment | 25.72% | 29.01% | 32.97% | 13.40% | 18.33% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -8.86% | -25.21% | -53.00% | -65.31% | -65.03% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -69.32% | -60.46% | -28.37% | -41.33% | -32.05% |
| Total Assets | -0.26% | -2.64% | -0.74% | -8.13% | -8.57% |
|
|
|||||
| Total Accounts Payable | -26.56% | -8.68% | 20.52% | 21.92% | 20.09% |
| Total Accrued Expenses | 28.42% | 20.73% | 13.95% | 11.94% | 8.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 25.84% | 0.80% | -12.62% | -16.16% | -24.96% |
| Total Finance Division Other Current Liabilities | -23.09% | -26.82% | -25.75% | -50.04% | -61.77% |
| Total Other Current Liabilities | -23.09% | -26.82% | -25.75% | -50.04% | -61.77% |
| Total Current Liabilities | -16.06% | -13.53% | -4.77% | -28.11% | -35.63% |
|
|
|||||
| Total Current Liabilities | -16.06% | -13.53% | -4.77% | -28.11% | -35.63% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 126.20% | 106.80% | 106.44% | -7.15% | -14.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.70% | 10.19% | 15.85% | 13.98% | 14.82% |
| Total Liabilities | 28.11% | 24.54% | 31.00% | -3.59% | -9.32% |
|
|
|||||
| Common Stock & APIC | 6.05% | 6.37% | 6.85% | 7.41% | 7.92% |
| Retained Earnings | -125.21% | -113.59% | -81.91% | -70.19% | -58.21% |
| Treasury Stock & Other | 3.29% | -118.99% | -28.17% | -285.35% | -154.53% |
| Total Common Equity | -8.44% | -10.58% | -9.35% | -9.46% | -8.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.44% | -10.58% | -9.35% | -9.46% | -8.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.44% | -10.58% | -9.35% | -9.46% | -8.35% |
|
|
|||||